Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study - PubMed

Affiliations

• PMID: 20795446

Free article

Pregnancy outcome in women with antiphospholipid syndrome on low-dose aspirin and heparin: a retrospective study

T Naru et al. East Mediterr Health J. 2010 Mar.

Free article

Abstract

This retrospective review of hospital records analysed pregnancy outcome with 2 different treatments for women with recurrent miscarriage diagnosed with antiphospholipid syndrome in the index pregnancy. Of 64 women, 29 had received aspirin and 35 aspirin plus heparin. Pregnancy-induced hypertension, prematurity, intrauterine growth restriction and neonatal death were considered as maternal and fetal complications. There were no significant differences in antenatal and maternal complications between the groups. HOwever, there were significant differences in mean anticardiolipin IgG antibody levels. Aspirin alone or in combination with parin was equally efficacious in women with antiphospholipid syndrome and recurrent miscarriage.

Similar articles

• Does aspirin have a role in improving pregnancy outcome for women with the antiphospholipid syndrome? A randomized controlled trial.

  Pattison NS, Chamley LW, Birdsall M, Zanderigo AM, Liddell HS, McDougall J. Pattison NS, et al. Am J Obstet Gynecol. 2000 Oct;183(4):1008-12. doi: 10.1067/mob.2000.106754. Am J Obstet Gynecol. 2000. PMID: 11035355 Clinical Trial.

• Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies.

  Triolo G, Ferrante A, Ciccia F, Accardo-Palumbo A, Perino A, Castelli A, Giarratano A, Licata G. Triolo G, et al. Arthritis Rheum. 2003 Mar;48(3):728-31. doi: 10.1002/art.10957. Arthritis Rheum. 2003. PMID: 12632426 Clinical Trial.

• Antibody profile of pregnant women with antiphospholipid syndrome and pregnancy outcome after treatment with low dose aspirin and low-weight-molecular heparin.

  Glasnović M, Bosnjak I, Vcev A, Soldo I, Kosuta M, Lenz B, Glasnović-Horvatić E, Soldo-Butković S, Mićunović N. Glasnović M, et al. Coll Antropol. 2007 Mar;31(1):173-7. Coll Antropol. 2007. PMID: 17598397

• A literature review on the antiphospholipid syndrome and the effect on childbearing.

  Vials JM. Vials JM. Midwifery. 2001 Jun;17(2):142-9. doi: 10.1054/midw.2000.0242. Midwifery. 2001. PMID: 11399135 Review.

• Heparin or aspirin or both in the treatment of recurrent abortions in women with antiphospholipid antibody (syndrome).

  Hoppe B, Burmester GR, Dörner T. Hoppe B, et al. Curr Opin Rheumatol. 2011 May;23(3):299-304. doi: 10.1097/BOR.0b013e328344c3f7. Curr Opin Rheumatol. 2011. PMID: 21346577 Review.

Cited by

• Effects of low-dose aspirin and heparin on the pregnancy outcome in women with antiphospholipid syndrome.

  Baiazid L, Hraib M. Baiazid L, et al. Ann Med Surg (Lond). 2022 Oct 31;83:104807. doi: 10.1016/j.amsu.2022.104807. eCollection 2022 Nov. Ann Med Surg (Lond). 2022. PMID: 36389195 Free PMC article.

• A retrospective review of antiphospholipid syndrome from a South Asian country.

  Mushtaq MZ, Ahsan Ali S, Sattar Z, Mahmood SBZ, Amber T, Riaz M. Mushtaq MZ, et al. Arch Rheumatol. 2021 Oct 18;37(1):31-39. doi: 10.46497/ArchRheumatol.2022.8979. eCollection 2022 Mar. Arch Rheumatol. 2021. PMID: 35949874 Free PMC article.

• EULAR recommendations for the management of antiphospholipid syndrome in adults.

  Tektonidou MG, Andreoli L, Limper M, Amoura Z, Cervera R, Costedoat-Chalumeau N, Cuadrado MJ, Dörner T, Ferrer-Oliveras R, Hambly K, Khamashta MA, King J, Marchiori F, Meroni PL, Mosca M, Pengo V, Raio L, Ruiz-Irastorza G, Shoenfeld Y, Stojanovich L, Svenungsson E, Wahl D, Tincani A, Ward MM. Tektonidou MG, et al. Ann Rheum Dis. 2019 Oct;78(10):1296-1304. doi: 10.1136/annrheumdis-2019-215213. Epub 2019 May 15. Ann Rheum Dis. 2019. PMID: 31092409 Free PMC article.

• Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults.

  Tektonidou MG, Andreoli L, Limper M, Tincani A, Ward MM. Tektonidou MG, et al. RMD Open. 2019 Apr 28;5(1):e000924. doi: 10.1136/rmdopen-2019-000924. eCollection 2019. RMD Open. 2019. PMID: 31168416 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • CORE
  • World Health Organization, Regional Office for the Eastern Mediterranean

• Medical

  • MedlinePlus Health Information